[1] Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016;37:2999-3058.
[2] Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73:3168-209.
[3] Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, et al. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb 2018;25:846-984.
[4] Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol 2000;53:273-7.
[5] Cotterchio M, Kreiger N, Darlington G, Steingart A. Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol 1999;9:283-9.
[6] Fujita M, Sato Y, Nagashima K, Takahashi S, Hata A. Validity assessment of self-reported medication use by comparing to pharmacy insurance claims. BMJ Open 2015;5:e009490,2015-009490.
[7] Hafferty JD, Campbell AI, Navrady LB, Adams MJ, MacIntyre D, Lawrie SM, et al. Self-reported medication use validated through record linkage to national prescribing data. J Clin Epidemiol 2018;94:132-42.
[8] Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT, PREVEND Study Group Prevention of REnal and Vascular ENT Stage Disease. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 2002;11:379-84.
[9] Haapea M, Miettunen J, Lindeman S, Joukamaa M, Koponen H. Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort. Int J Methods Psychiatr Res 2010;19:88-96.
[10] Richardson K, Kenny RA, Peklar J, Bennett K. Agreement between patient interview data on prescription medication use and pharmacy records in those aged older than 50 years varied by therapeutic group and reporting of indicated health conditions. J Clin Epidemiol 2013;66:1308-16.
[11] Ministry of Health, Labour and Welfare. Available at https://www.mhlw.go.jp/english/ (Accessed August 28, 2019).
[12] Harada S, Takebayashi T, Kurihara A, Akiyama M, Suzuki A, Hatakeyama Y, et al. Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men. Environ Health Prev Med 2016;21:18-26.
[13] Iida M, Harada S, Kurihara A, Fukai K, Kuwabara K, Sugiyama D, et al. Profiling of plasma metabolites in postmenopausal women with metabolic syndrome. Menopause 2016;23:749-58.
[14] Fukai K, Harada S, Iida M, Kurihara A, Takeuchi A, Kuwabara K, et al. Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men. PLoS One 2016;11:e0164877.
[15] Harada S, Hirayama A, Chan Q, Kurihara A, Fukai K, Iida M, et al. Reliability of plasma polar metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry. PLoS One 2018;13:e0191230.
[16] Ministry of Health, Labour and Welfare. Various Information of Medical Fee. Iyakuhin master. Available at http://www.iryohoken.go.jp/shinryohoshu/downloadMenu/ (Accessed October 10, 2018).
[17] Takahisa. F and Y. Yazaki. Therapeutics Manual 2019. Igaku-shoin; 2019. [In Japanese].
[18] WHO. Guideline for ATC classification and DDD assignment 2018. Available at https://www.whocc.no/filearchive/publications/2018_guidelines_web.pdf (Accessed October 10, 2018).
[19] Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997;50:619-25.
[20] Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
[21] Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
[22] Tanaka T, Okamura T, Yamagata Z, Takebayashi T, Tamura U, Kusaka Y, et al. Awareness and treatment of hypertension and hypercholesterolemia in Japanese workers: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Hypertens Res 2007;30:921-8.